Clinical Trials Sponsored by M.D. Anderson Cancer Center - Houston

Total 5464 results

M.D. Anderson Cancer Center

Completed

Allo Transplantation With Mylotarg, Fludarabine and Melphalan for AML, CML and MDS

Chronic Lymphocytic Leukemia | Myelodysplastic Syndrome | Acute Myelogenous Leukemia

United States
M.D. Anderson Cancer Center

Completed

Intravenous Estramustine With Taxol in Hormone Refractory Prostate Adenocarcinoma

Prostate Cancer

United States
M.D. Anderson Cancer Center

Completed

Quantitative Diffusion and Fat Imaging of the Spine

Osteoporosis

United States
M.D. Anderson Cancer Center

Completed

Ambulatory Cancer Pain Management: A Feasibility Study

Breast Cancer | Colorectal Cancer | Lung Cancer | Prostate Cancer

United States
M.D. Anderson Cancer Center

Completed

Topotecan, Ifosfamide and Carboplatin in Children and Young Adults With Solid Tumors

Solid Tumors

United States
M.D. Anderson Cancer Center

Terminated

Doxercalciferol in Recurrent Pediatric Solid Tumors

Solid Tumors

United States
M.D. Anderson Cancer Center

Completed

Perioperative Kinetics of Reactive Hyperemia Using Noninvasive Digital Thermal Monitoring

Abdominal Surgery | Thoracic Surgery

United States
M.D. Anderson Cancer Center

Completed

Combined Strength Training and Functional Endurance Exercise Regimen on Cancer -Related Fatigue and Physical Performance

Breast Cancer | Fatigue

United States
M.D. Anderson Cancer Center

Completed

Feasibility Study of Collecting Multicenter Chronic GVHD Data

Graft-Versus-Host Disease

United States
M.D. Anderson Cancer Center

Completed

Experience of Having Chronic Graft-Versus-Host Disease

Graft-Versus-Host Disease

United States
M.D. Anderson Cancer Center

Completed

Validating M.D. Anderson Symptom Inventory (MDASI-GI) in GI Cancer Patients Under Chemotherapy

Gastrointestinal Cancer

United States
M.D. Anderson Cancer Center

Completed

Paclitaxel Administered by HAI to Patients With Advanced Cancer and Dominant Liver Involvement

Advanced Cancer

United States
M.D. Anderson Cancer Center

Completed

Mifepristone for Patients With Endometrial Cancer and LGESS

Endometrial Cancer

United States
M.D. Anderson Cancer Center

Completed

Sexual Behavior in Oropharyngeal Patients Versus Head and Neck Cancer Patients, With or Without HPV Infection

Head and Neck Cancer | Oropharyngeal Cancer | Human Papillomavirus Infection

United States
M.D. Anderson Cancer Center

Completed

Evaluation of Antiproliferative Effects of Arimidex in Ductal Lavage Fluid in Patients With Breast Cancer

Breast Cancer

United States
M.D. Anderson Cancer Center

Completed

Effect on Clip Markers After Vacuum-Assisted Biopsy by Postprocedure Mammogram

Breast Cancer

United States
M.D. Anderson Cancer Center

Completed

Busulfan and Fludarabine in Patients With AML and MDS

Leukemia

United States
M.D. Anderson Cancer Center

Completed

Evaluate PKs and Efficacy Assessment of Palifermin in Patients With Sarcoma

Sarcoma | Oral Mucositis

United States
M.D. Anderson Cancer Center

Completed

Extraperitoneal Lymph Node Dissection in Patients With Cervical Cancer

Cervical Cancer

United States
M.D. Anderson Cancer Center

Completed

Caphosol in Sarcoma Patients With Mucositis

Sarcoma | Oral Mucositis

United States
M.D. Anderson Cancer Center

Withdrawn

Proton Therapy With Capecitabine for Rectal Cancer

Rectal Cancer
M.D. Anderson Cancer Center

Withdrawn

Interstitial Fluid Pressure (IFP) Pilot Study in Melanoma Patients

Melanoma | Advanced Cancers
M.D. Anderson Cancer Center

Terminated

Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Indolent Lymphoid Malignancies

Lymphoma | Leukemia | Myeloma

United States
M.D. Anderson Cancer Center

Completed

The Role of the EKG in Anticancer Drug Development

Advanced Cancer

United States
M.D. Anderson Cancer Center

Terminated

Breast Magnetic Resonance Imaging (MRI) Screening After Mantle Radiation Therapy

Breast Cancer

United States
M.D. Anderson Cancer Center

Completed

Autologous Transplantation for Chronic Myelogenous Leukemia

Chronic Myelogenous Leukemia

United States
M.D. Anderson Cancer Center

Completed

Latent Tuberculosis Infection in Cancer Patients

Advanced Cancer

United States
M.D. Anderson Cancer Center

Not yet recruiting

Enfortumab Vedotin With Radiation for Locally Advanced Bladder Cancer (CONSOLIDATE)

Advanced Bladder Cancer

United States
M.D. Anderson Cancer Center

Not yet recruiting

Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

Systemic Sclerosis | Autoimmune Disorders

United States
M.D. Anderson Cancer Center

Recruiting

Goals of Care Discussion for Patients With Advanced Lung and Gastrointestinal Cancer in the Emergency Department of a Comprehensive Cancer Center

Lung Cancer | Gastrointestinal Cancer

United States
M.D. Anderson Cancer Center

Not yet recruiting

18F-AraG PET/CT as a Non-Invasive Imaging Biomarker for Chemoradiation Treatment Response in Esophageal Cancer

Esophageal Cancer

United States
M.D. Anderson Cancer Center

Recruiting

Psycho-Spiritual Management for Patients With Advanced Cancer and Their Family Caregivers

Cancer

United States
M.D. Anderson Cancer Center

Not yet recruiting

Phase II Study of REPotrectinib With or Without Fulvestrant in Patients With Hormone Receptor-positive Human Epidermal Growth Factor 2-negative Metastatic Invasive LObular Carcinoma Who Received a Prior Endocrine Therapy in Combination With Cyclin-dependent Kinase 4 and 6 Inhibitor (REPLOT Trial)

Hormone Receptor-positive Human Epidermal Growth Factor 2-negative | Metastatic Invasive LObular Carcinoma

United States
M.D. Anderson Cancer Center

Not yet recruiting

Establishing a Tumor Registry of Patients With Mesonephric-like Adenocarcinoma (MLA)

Mesonephric-like Adenocarcinoma

United States
M.D. Anderson Cancer Center

Not yet recruiting

Open-label Phase 2 Study of Avutometinib (RAF/MEK Clamp) in Combination With Defactinib (FAK Inhibitor) and Cetuximab in Patients With Unresectable, Anti-EGFR-Refractory Advanced Colorectal Cancer

Advanced Colorectal Cancer

United States
M.D. Anderson Cancer Center

Recruiting

A Randomized Phase II Basket Trial EXTENDing Efficacy of Systemic Therapy With Local Consolidative Therapy for OligoProgressive Metastatic Disease (EXTEND-OP)

OligoProgressive Metastatic Disease

United States
M.D. Anderson Cancer Center

Recruiting

Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology

Dyspnea

United States
M.D. Anderson Cancer Center

Not yet recruiting

Validation of the Screen of Cancer Survivorship - Occupational Therapy Services (SOCS-OTS) Tool for Use in a Physical Medicine Rehabilitation Clinic

Cancer | Occupational Therapy

United States
M.D. Anderson Cancer Center

Not yet recruiting

Hypophysectomy by Stereotactic Radiosurgery for Cancer-Related Pain

Hypophysectomy

United States
M.D. Anderson Cancer Center

Not yet recruiting

Phase Ib/II Study Assessing the Clinical Activity and Safety of Brexucabtagene Autoleucel as a Consolidation in Patients With Relapsed/Refractory (R/R) and Newly Diagnosed B-cell Acute Lymphocytic Leukemia (ALL) Post Cytoreduction With Mini-HCVD-inotuzumab-blinatumomab/HCVAD-inotuzumab-blinatumomab

B-cell Acute Lymphocytic Leukemia | Relapsed/Refractory

United States
M.D. Anderson Cancer Center

Not yet recruiting

Low-Dose Sirolimus to Increase Hematopoietic Function in Patients With RUNX1 Familial Platelet Disorder

Familial Platelet Disorder | Hematopoietic

United States
M.D. Anderson Cancer Center

Recruiting

5x-Multiplier vs 3-Tier Model for Discharge Opioid Prescriptions After Intra-abdominal Cancer Surgery: A Randomized Clinical Trial

Intra-abdominal Cancer

United States
M.D. Anderson Cancer Center

Recruiting

Pilot Trial of Fecal Microbiota Transplantation for Lymphoma Patients Receiving Axicabtagene Ciloleucel Therapy.

Lymphoma

United States
M.D. Anderson Cancer Center

Recruiting

Effect of Olanzapine on Opioid Craving and Misuse Among Patients Receiving Opioids for Cancer-related Pain: A Pilot Double-Blind, Randomized Control Trial

Misuse, Opioid

United States
M.D. Anderson Cancer Center

Recruiting

Radiologic Pathologic Correlation of Imaging to Distinguish True Progression From Pseudoprogression in Brain Malignancies

Brain Malignancies | Pseudoprogression

United States
M.D. Anderson Cancer Center

Recruiting

Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia After Chemoradiation

Esophageal Cancer | Chemoradiation | Lymphopenia | Pneumococcal Vaccine

United States
M.D. Anderson Cancer Center

Recruiting

Phase II Randomized-registry Embedded Study of Lymphoscintigraphy for Oropharyngeal Neoplasms to Enable Risk-adapted Nodal Guidance for Robotic Surgery and/or Radiotherapy (LONE-RANGR2)

Oropharyngeal Neoplasms | Robotic Surgery and/or Radiotherapy | Lymphoscintigraphy

United States
M.D. Anderson Cancer Center

Recruiting

Methylnatrexone In Resectable Head and Neck Squamous Cell Carcinoma (MINK). A "Window of Opportunity" Pilot Study.

Head and Neck Squamous Cell Carcinoma

United States
M.D. Anderson Cancer Center

Recruiting

A Pilot Presurgical Trial of REGN5678 (Anti-PSMA x CD28) in Patients With High-risk, Localized Prostate Cancer Followed by Radical Prostatectomy

Prostate Cancer | Radical Prostatectomy

United States
M.D. Anderson Cancer Center

Recruiting

Minimally-invasive Stabilization of Pelvic Metastases With Photodynamic Nails: A Multi-center Prospective Study of Functional Outcome

Pelvic Metastasis

United States

3

Subscribe